Raj Chakraborty: Recent Clinical Trials for Newly Diagnosed Multiple Myeloma
By Raj Chakraborty, MD - Last Updated: November 14, 2022Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, speaks about promising results from current clinical trials for newly diagnosed multiple myeloma.
Advertisement
Post Tags:MM
Advertisement
Related Posts
Experts call for rethinking smoldering myeloma as a distinct disease, with new data supporting early risk-based intervention.
Experts discuss the link between dietary patterns and blood cancer risk and the shortcomings of epidemiological studies.
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
The agent is designed to be an option for cases where CAR T-cell therapies or first-generation bispecifics are unsuccessful.
In the US, a BLA submitted for these two particular combinations is currently under review at the FDA.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.